Rituximab Maintenance Called 'New Standard' for Mantle Cell Lymphoma - OncologySTAT
Links shared publicly online about this topic.
- 181total visits
Rituximab Maintenance Called 'New Standard' for Mantle Cell Lymphoma - OncologySTAT
View full resource at oncologystat.com
Tags: Cancer, Lymphoma, Non-Hodgkin Lymphoma, Non-Hodgkin Lymphoma Medication, Rheumatoid Arthritis Medication, Rituxan, MabThera, Medical
Most Recently Shared on June 30, 2011 at 3:28 pm By:
Story of the Week With Expert Commentary: Rituximab Maintenance Called 'New Standard' for Mantle Cell Lymphoma http://t.co/O6z8CT7
Rituximab Maintenance Called "New Standard" for Mantle Cell Lymphoma : Internal Medicine News
internalmedicinenews.com — “Internal Medicine News Digital Network is the online destination and multimedia properties of Internal Medicine News, the independent news publication. Our breaking news covers all areas of internal medicine including adolescent medicine; cardiovascular disease; dermatology; diabetes, endocrinology and metabolism; gastroenterology; geriatric medicine; infectious diseases; mental health; oncology and hematology; nephrology and urology; neurology; pulmonary disease and sleep medicine; practice tre” View full resource at internalmedicinenews.com
Most Recently Shared on June 20, 2011 at 4:07 pm By:
Bob Finn - Medical News Net Health News
Rituximab Maintenance Called "New Standard" for Mantle Cell Lymphoma, Sara Freeman reports: http://bit.ly/kcwjUF
Medical News: ASH: New Combo Challenges Standard Treatment for Indolent Lymphomas - in Meeting Coverage, ASH: Hematology from MedPage Today
medpagetoday.com — “NEW ORLEANS -- Bendamustine (Treanda) could replace the so-called CHOP regimen as the optimal partner with rituximab as the standard first-line treatment for indolent and mantle cell lymphomas, resear” View full resource at medpagetoday.com
Most Recently Shared on December 6, 2009 at 5:29 am By:
ASH: New Combo Challenges Standard Treatment for Indolent Lymphomas (CME/CE) http://ow.ly/1671Wn
Advertisement
